Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.
Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E.
Murphy G, et al. Among authors: cross aj.
Int J Cancer. 2009 May 1;124(9):2148-51. doi: 10.1002/ijc.24079.
Int J Cancer. 2009.
PMID: 19065655
Free PMC article.
Clinical Trial.